ExLibris header image
SFX Logo
Title: The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
Source:

Nature Genetics [1061-4036] Andersson, Anna yr:2015


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Ramsay, Robert G. "Directly targeting transcriptional dysregulation in cancer." Nature Reviews. Cancer 15.11 (2015): 686-694. Link to SFX for this item
2. Pui, C. "Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study." Lancet oncology 16.4 (2015): 465-474. Link to SFX for this item
3. Shinoda, K. "Genetic and functional characterization of clonally derived adult human brown adipocytes." Nature medicine 21.4 (2015): 389-394. Link to SFX for this item
4. Cario, G. "Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol." Blood 115.26 (2010): 5393-5397. Link to SFX for this item
5. Biondi, A. "Biological and therapeutic aspects of infant leukemia." Blood 96.1 (2000): 24-33. Link to SFX for this item
6. Rambaldi, T. "Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)." Blood 113.18 (2009): 4153-62. Link to SFX for this item
7. Ouyang, J. "The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia." American journal of hematology 90.6 (2015): 504-10. Link to Full Text for this item Link to SFX for this item
8. Uttarkar, S. "Targeting the transcription factor Myb by small-molecule inhibitors." Experimental hematology 47 (2017): 31-35. Link to SFX for this item
9. Cross, Ryan S. "Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein." Clinical and Translational Immunology 4.1 (2015). Link to Full Text for this item Link to SFX for this item
10. Attardi, Laura D. "Cancer: A piece of the p53 puzzle." Nature 520.7545 (2015): 37-38. Link to Full Text for this item Link to SFX for this item
11. Steinberg, Gregory R. "Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis." Nature medicine 21.2 (2014): 166-172. Link to SFX for this item
12. Waibel, M. "Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors." Cell Reports 5.4 (2013): 1047-1059. Link to SFX for this item
13. Sharma, Sharan P. "Targeting the B-cell signalling pathway in CLL and MCL." Lancet oncology 14.9 (2013). Link to SFX for this item
14. Zuber, J. "An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance." Genes & development 25.15 (2011): 1628-1640. Link to Full Text for this item Link to SFX for this item
15. Ensor, Hannah M. "Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial." Blood 117.7 (2011): 2129-36. Link to SFX for this item
16. Mullighan, Charles G. "New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice." Clinical cancer research 17.3 (2010): 396-400. Link to SFX for this item
17. Hashimoto, A. "Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism." Atherosclerosis 189.2 (2006): 350-357. Link to SFX for this item
18. Cannon, B. "Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans)." International journal of obesity 34.10 (2010): 7-16. Link to Full Text for this item Link to SFX for this item
19. Krumpelmann, S. "Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation?" Journal of clinical oncology 13.12 (1995): 2954-60. Link to SFX for this item
20. Yoda, A. "Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia." Proceedings of the National Academy of Sciences of the United States of America 107.1 (2009): 252-257. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced